Kim Jae-Seok, Yang Jae-Won, Yoo Jin Sae, Choi Seung Ok, Han Byoung-Geun
Department of Nephrology, Yonsei University Wonju College of Medicine, Wonju, Kang-won, Korea.
PLoS One. 2017 Sep 13;12(9):e0184764. doi: 10.1371/journal.pone.0184764. eCollection 2017.
Chronic fluid overload is common in patients with chronic kidney disease (CKD) and can with time lead to diastolic dysfunction and heart failure. We investigated whether markers of fluid status, such as NT-proBNP and bioimpedance spectroscopy (BIS), can predict echocardiographic findings of diastolic dysfunction in non-dialysis CKD5 patients.
BIS, echocardiography, and measurement of serum NT-proBNP were performed in patients with non-dialysis CKD stage 5 at a single study visit. E/e´ ratio reflect mean LV diastolic pressure and a ratio greater than 15 was used as a definition of diastolic dysfunction.
Eighty-four patients were analyzed. Forty-six patients (54.76%) had E/e´ ratio ≤15 and 38 patients (45.24%) had E/e´ > 15 (diastolic dysfunction). Patients with E/e´>15 had significantly higher serum NT-proBNP (14,650 pg/mL) than patients with to E/e´≤15 (4,271 pg/mL) and had more overhydration (OH), 5.1 liters compared to 2.4 liters. The cut-off values predicting diastolic dysfunction were found to be 2,797 pg/mL for NT-proBNP and 2.45 liters for OH.
Regular monitoring of fluid status by BIS and NT-proBNP can be used to find patient with risk of developing diastolic dysfunction. Treatments to correct fluid overload may reduce the risk of developing diastolic dysfunction and improve cardiovascular outcome in patients with CKD.
慢性液体超负荷在慢性肾脏病(CKD)患者中很常见,随着时间推移可导致舒张功能障碍和心力衰竭。我们研究了诸如N末端B型利钠肽原(NT-proBNP)和生物电阻抗光谱法(BIS)等液体状态标志物是否能预测非透析CKD5期患者舒张功能障碍的超声心动图表现。
在单次研究访视中,对非透析CKD5期患者进行BIS、超声心动图检查及血清NT-proBNP测定。E/A比值反映左心室平均舒张压,比值大于15被用作舒张功能障碍的定义。
分析了84例患者。46例患者(54.76%)的E/A比值≤15,38例患者(45.24%)的E/A>15(舒张功能障碍)。E/A>15的患者血清NT-proBNP水平(14,650 pg/mL)显著高于E/A≤15的患者(4,271 pg/mL),且水负荷过多(OH)情况更严重,分别为5.1升和2.4升。预测舒张功能障碍的NT-proBNP临界值为2,797 pg/mL,OH临界值为2.45升。
通过BIS和NT-proBNP定期监测液体状态可用于发现有发生舒张功能障碍风险的患者。纠正液体超负荷的治疗可能降低CKD患者发生舒张功能障碍的风险并改善心血管结局。